Table 2. Anti-HIV Activity of FC131 and the Derivatives 15a−g.
EC50 (nM)a |
|||
---|---|---|---|
peptide | NL4-3 | IIIB | Ba-L |
FC131 (2) | 21 ± 4.3 | 21 ± 5.9 | −b |
FC122 (3) | 7.6 ± 0.34 | 7.6 ± 1.1 | −b |
15a | 1.3 ± 0.43 | 0.61 ± 0.10 | −b |
15b | 1.4 ± 0.44 | 1.0 ± 0.23 | −b |
15c | 2.2 ± 0.04 | 2.0 ± 0.59 | −b |
15d | 4.4 ± 1.0 | 6.3 ± 0.47 | −b |
15e | 1.9 ± 0.47 | 1.2 ± 0.29 | −b |
15f | 300 ± 57 | 258 ± 47 | −b |
15g | 248 ± 55 | 238 ± 37 | −b |
EC50 is the concentration that blocks HIV-1 infection by 50%.
No inhibitory activity was observed at 10 μM.